{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:25:12Z","timestamp":1784935512061,"version":"3.55.0"},"reference-count":16,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2022,12,1]]},"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1183\/13993003.01402-2022","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T16:35:16Z","timestamp":1671035716000},"page":"2201402","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor\u2013tezacaftor\u2013ivacaftor, Germany, 2012\u20132021"],"prefix":"10.1183","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9084-4968","authenticated-orcid":false,"given":"Felix C.","family":"Ringshausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Sauer-Heilborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"B\u00fcttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9582-1025","authenticated-orcid":false,"given":"Anna-Maria","family":"Dittrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Schwerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"N\u00e4hrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9947-7356","authenticated-orcid":false,"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"2024102103104945000_61.1.2201402.1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cyst Fibros"},{"key":"2024102103104945000_61.1.2201402.2","unstructured":"Naehrlich L , Burkhart M , Wosniok J . German Cystic Fibrosis Registry \u2013 Annual Data Report 2020. Bonn, Mukoviszidose e.V. and Mukoviszidose Institut gGmbH, 2021."},{"key":"2024102103104945000_61.1.2201402.3","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2024102103104945000_61.1.2201402.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105185"},{"key":"2024102103104945000_61.1.2201402.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409547"},{"key":"2024102103104945000_61.1.2201402.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709847"},{"key":"2024102103104945000_61.1.2201402.7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1164\/rccm.202008-3176LE","article-title":"Safety and efficacy of elexacaftor\/tezacaftor\/ivacaftor for 24 weeks or longer in people with cystic fibrosis and one or more F508del alleles: interim results of an open-label phase 3 clinical trial","volume":"203","author":"Griese","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103104945000_61.1.2201402.8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jcf.2022.04.002","article-title":"A new era has dawned for persons with cystic fibrosis; however many knowledge gaps exist in our efforts to improve care","volume":"21","author":"Hadjiliadis","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2024102103104945000_61.1.2201402.9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jcf.2021.10.005","article-title":"CFTR modulation with elexacaftor\u2013tezacaftor\u2013ivacaftor in people with cystic fibrosis assessed by the beta-adrenergic sweat rate assay","volume":"21","author":"Pallenberg","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2024102103104945000_61.1.2201402.10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.202201-0219OC","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on lung clearance index and magnetic resonance imaging in patients with cystic fibrosis and one or two F508del alleles","volume":"206","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103104945000_61.1.2201402.11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.202110-2249OC","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on CFTR function in patients with cystic fibrosis and one or two F508del alleles","volume":"205","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103104945000_61.1.2201402.12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jcf.2021.05.009","article-title":"Short-term effect of elexacaftor\u2013tezacaftor\u2013ivacaftor on lung function and transplant planning in cystic fibrosis patients with advanced lung disease","volume":"20","author":"Bermingham","year":"2021","journal-title":"J Cyst Fibros"},{"key":"2024102103104945000_61.1.2201402.13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202011-4153OC"},{"key":"2024102103104945000_61.1.2201402.14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcf.2022.01.012","article-title":"Sustained effectiveness of elexacaftor\u2013tezacaftor\u2013ivacaftor in lung transplant candidates with cystic fibrosis","volume":"21","author":"Martin","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2024102103104945000_61.1.2201402.15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/rccm.202109-2121LE","article-title":"Major decrease in lung transplantation for patients with cystic fibrosis in France","volume":"205","author":"Martin","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103104945000_61.1.2201402.16","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S1569-1993(22)00861-X","article-title":"Long-term safety and efficacy of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from an open-label extension study","volume":"21","author":"Griese","year":"2022","journal-title":"J Cystic Fibros"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01402-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:12:13Z","timestamp":1740377533000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01402-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,12]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1183\/13993003.01402-2022"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01402-2022","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]}}}